P0342A STUDY OF TREATMENT WITH RITUXIMAB IN REFRACTORY LUPUS NEPHRITIS
Sign Up to like & getrecommendations! Published in 2020 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaa142.p0342
Abstract: SLE patients have 40% to 70% life time risk of developing lupus nephritis (LN). In LN patients rate of end-stage renal disease is 10%, remaining constant in the last 30 years, even after the emergence… read more here.
Keywords: rituximab; refractory lupus; treatment; study ... See more keywords
The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis
Sign Up to like & getrecommendations! Published in 2017 at "Lupus"
DOI: 10.1177/0961203316686703
Abstract: Objective The treatment of refractory lupus nephritis (LN) remains challenging for clinicians because these patients either do not respond to conventional therapy or relapse during the maintenance treatment period. The aim of this study was… read more here.
Keywords: refractory lupus; treatment; bortezomib combined; combined glucocorticoids ... See more keywords
Intravenous immunoglobulin in the management of refractory lupus profundus
Sign Up to like & getrecommendations! Published in 2022 at "Lupus"
DOI: 10.1177/09612033221099873
Abstract: Lupus profundus, often known as lupus panniculitis, is a rare form of persistent cutaneous lupus erythematosus. It usually manifests as painful plaques or nodules that can ulcerate and cause atrophy and scarring. It may respond… read more here.
Keywords: management refractory; lupus profundus; immunoglobulin management; refractory lupus ... See more keywords
Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis—a series study of 20 patients
Sign Up to like & getrecommendations! Published in 2022 at "Lupus"
DOI: 10.1177/09612033221126848
Abstract: Background Autologous hematopoietic cell transplantation (ASCT) improves immunologic homeostasis in autoimmune diseases. ASCT-treated refractory lupus nephritis (LN) has been reported. Nevertheless, the long-term outcome of patients with refractory LN after ASCT remains unknown. This study… read more here.
Keywords: long term; cell; term; transplantation ... See more keywords
A new promising biological agent for refractory lupus nephritis: Telitacicept
Sign Up to like & getrecommendations! Published in 2023 at "Pakistan Journal of Medical Sciences"
DOI: 10.12669/pjms.39.4.7542
Abstract: doi: https://doi.org/10.12669/pjms.39.4.7542 How to cite this: Liu S, Yu X, Li X. A new promising biological agent for refractory lupus nephritis: Telitacicept. Pak J Med Sci. 2023;39(4):---------. doi: https://doi.org/10.12669/pjms.39.4.7542 read more here.
Keywords: agent refractory; lupus nephritis; promising biological; biological agent ... See more keywords
Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1062919
Abstract: Objectives IGU (IGU), a novel immunomodulatory agent for rheumatoid arthritis, has been shown to be effective and safe as monotherapy in a small population with refractory lupus nephritis (LN). The aim of this prospective study… read more here.
Keywords: refractory; therapy; lupus nephritis; refractory lupus ... See more keywords
Treatment of refractory lupus nephritis using leflunomide: A prospective study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1133183
Abstract: Introduction The condition of refractory lupus nephritis (LN) negatively affects the prognosis and life expectancy of the patients, posing a challenge to manage in clinical. This interventional study evaluated the efficacy as well as safety… read more here.
Keywords: refractory; lupus nephritis; refractory lupus; response ... See more keywords